Parallel Advisors, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$60
-16.7%
10.0%0.00%
Q2 2023$72
-2.7%
10.0%0.00%
Q1 2023$74
+10.4%
10.0%0.00%
Q4 2022$671
-66.7%
0.00%
Q3 2022$030.0%0.00%
Q4 2021$030.0%0.00%
Q3 2021$0
-100.0%
3
-50.0%
0.00%
Q4 2019$1,0000.0%60.0%0.00%
Q3 2019$1,0006
+200.0%
0.00%
Q2 2017$020.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders